Sign in to continue:

Friday, July 31st, 2026

Day: May 5, 2026

us corporate news

Axsome Therapeutics Q1 2026 10-Q Report: Financial Statements, Risk Factors, and Management Discussion

Minichart
May 5, 2026

Axsome Therapeutics, Inc. Q1 2026 Financial Report - Investo...

Continue Reading 0
SGX corporate News

Prudential plc Announces Director Share Acquisition Disclosure and Company Overview 2026

Minichart
May 5, 2026

Prudential plc - Director Share Acquisition Announcement ...

Continue Reading 0
us corporate news

Firefly Aerospace Inc. Q1 2026 SEC 10-Q Report: Financials, Risk Factors, and Management Analysis

Minichart
May 5, 2026

Firefly Aerospace Inc. Q1 2026 Financial Report: Key Highlig...

Continue Reading 0
us corporate news

Paramount Skydance Corporation Q1 2026 Financial Results and Consolidated Statements of Operations

Minichart
May 5, 2026

Paramount Skydance Corporation Q1 2026 Financial Report: Key...

Continue Reading 0
us corporate news

OSI Systems Inc. 2026 Q3 Financial Report: Key Financial Statements, Results, and SEC Filings

Minichart
May 5, 2026

OSI Systems Q3 FY2026 Financial Report: Key Takeaways for In...

Continue Reading 0
us corporate news

Crawford & Company Q1 2026 Quarterly Report: Financial Statements, Market Risks, and Management Discussion

Minichart
May 5, 2026

Crawford & Company Q1 2026 Results: Key Insights for Investo...

Continue Reading 0
us corporate news

Lattice Semiconductor Q1 2026 Earnings Report: Financial Statements, Results, and Key Disclosures

Minichart
May 5, 2026

Lattice Semiconductor Corporation Q1 2026 Earnings Report: K...

Continue Reading 0
us corporate news

Inno Holdings Inc. Announces 1-for-20 Reverse Stock Split to Maintain Nasdaq Compliance

Minichart
May 5, 2026

Inno Holdings Inc. Announces 1-for-20 Reverse Stock Split Am...

Continue Reading 0
us corporate news

Cryoport Reports 16% Revenue Growth in Q1 2026, Raises Full-Year Guidance and Highlights Record Cell & Gene Therapy Support

Minichart
May 5, 2026

Cryoport Q1 2026 Financial Results - Investor Analysis ...

Continue Reading 0
us corporate news

Rezolute Announces Positive Phase 3 sunRIZE Results for Ersodetug in Congenital Hyperinsulinism, Shows Significant Glycemic Improvements and FDA Progress 1234

Minichart
May 5, 2026

Rezolute Announces Positive Phase 3 sunRIZE Study Data for E...

Continue Reading 0